Neuroscience News and Research

RSS

Study: Hypersensitivity to motion may provide clues to fundamental cause of autism

Children with autism see simple movement twice as quickly as other children their age, and this hypersensitivity to motion may provide clues to a fundamental cause of the developmental disorder, according to a new study.

9 May 2013

Missing link between over-stimulation and destruction of brain tissue identified

In many neurodegenerative diseases the neurons of the brain are over-stimulated and this leads to their destruction. After many failed attempts and much scepticism this process was finally shown last year to be a possible basis for treatment in some patients with stroke. But very few targets for drugs to block this process are known.

9 May 2013

Scientists identify TR4 protein that drives the formation of pituitary tumors in Cushing's disease

Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.

8 May 2013

Scientists discover how Alzheimer's pharmaceuticals sharpen the brain's performance

Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.

8 May 2013

Restless legs syndrome and insomnia: a possible explanation

Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge to move the legs is treated successfully with medication.

7 May 2013

Janssen enrolls patients in expanded access program for mantle cell lymphoma

Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.

7 May 2013

Complex network of molecules controls formation and activity of neuronal connections

Environment moulds behaviour - and not just that of people in society, but also at the microscopic level. This is because, for their function, neurons are dependent on the cell environment, the so-termed extracellular matrix.

7 May 2013

First Edition: May 7, 2013

Today's headlines include reports about two new studies exploring whether the slowdown in the nation's health spending growth rates is, in fact, due more to structural changes in the health ystem than to the economy.

7 May 2013

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.

7 May 2013

Neuroperspective reviews status and prospects of therapeutics for Parkinson's disease

NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's.

7 May 2013

Mutations in Ggamma13 gene may contribute to certain forms of smell disorders in humans

Researchers at the Monell Center and collaborators have identified a protein that is critical to the ability of mammals to smell. Mice engineered to be lacking the Ggamma13 protein in their olfactory receptors were functionally anosmic - unable to smell.

7 May 2013

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round.

6 May 2013

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Cancer chemotherapy can cause peripheral neuropathy-nerve damage often resulting in pain and muscle weakness in the arms and legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that chemo also induces an insidious type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation.

6 May 2013

Discovery raises hope for severe forms of human epilepsy

Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.

5 May 2013

Springer releases new books series focusing on human performance

Springer, a leading global scientific publisher, is launching a new book series entitled Trends in Augmentation of Human Performance. The series will focus on the enhancement of human skills, attributes and competencies through the use of technology, medicine and therapy.

3 May 2013

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

Shore Medical Center is pleased to announce it has entered into an affiliation agreement with The Cancer Institute of New Jersey - the state's only National Cancer Institute-designated Comprehensive Cancer Center.

3 May 2013

Hypothalamus controls aging throughout the body, scientists report

While the search continues for the Fountain of Youth, researchers may have found the body's "fountain of aging": the brain region known as the hypothalamus.

2 May 2013

Study discusses how mind-body class helps medical students better manage stress

A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.

2 May 2013

UCLA study shows individuals with BDD have global bad wiring in their brains

Body dysmorphic disorder is a disabling but often misunderstood psychiatric condition in which people perceive themselves to be disfigured and ugly, even though they look normal to others. New research at UCLA shows that these individuals have abnormalities in the underlying connections in their brains.

30 Apr 2013

Researchers find that VEGF may not have any prognostic value for advanced prostate cancer

The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University Hospital and other institutions found in a retrospective study published online April 25 in the journal BMC Radiation Oncology.

30 Apr 2013

Neuroscience News and Research

Study: Hypersensitivity to motion may provide clues to fundamental cause of autism

Missing link between over-stimulation and destruction of brain tissue identified

Scientists identify TR4 protein that drives the formation of pituitary tumors in Cushing's disease

Scientists discover how Alzheimer's pharmaceuticals sharpen the brain's performance

Restless legs syndrome and insomnia: a possible explanation

Janssen enrolls patients in expanded access program for mantle cell lymphoma

Complex network of molecules controls formation and activity of neuronal connections

First Edition: May 7, 2013

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Neuroperspective reviews status and prospects of therapeutics for Parkinson's disease

Mutations in Ggamma13 gene may contribute to certain forms of smell disorders in humans

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Discovery raises hope for severe forms of human epilepsy

Springer releases new books series focusing on human performance

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

Hypothalamus controls aging throughout the body, scientists report

Study discusses how mind-body class helps medical students better manage stress

UCLA study shows individuals with BDD have global bad wiring in their brains

Researchers find that VEGF may not have any prognostic value for advanced prostate cancer

Neuroscience - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News